Maternal immune activation (mIA) during pregnancy is hypothesised to disrupt offspring neurodevelopment and predispose offspring to neurodevelopmental disorders such as schizophrenia. Rodent models of mIA have explored possible mechanisms underlying this paradigm and provide a vital tool for preclinical research. However, a comprehensive analysis of the molecular changes that occur in mIA-models is lacking, hindering identification of robust clinical targets. This systematic review assesses mIA-driven transcriptomic and epigenomic alterations in specific offspring brain regions. Across 118 studies, we focus on 88 candidate genes and show replicated changes in expression in critical functional areas, including elevated inflammatory markers, and reduced myelin and GABAergic signalling proteins. Further, disturbed epigenetic markers at nine of these genes support mIA-driven epigenetic modulation of transcription. Overall, our results demonstrate that current outcome measures have direct relevance for the hypothesised pathology of schizophrenia and emphasise the importance of mIA-models in contributing to the understanding of biological pathways impacted by mIA and the discovery of new drug targets.
Exposure to maternal immune activation (MIA) in utero significantly elevates the risk of developing schizophrenia and other neurodevelopmental disorders. To understand the biological mechanisms underlying the link between MIA and increased risk, preclinical animal models have focussed on specific signalling pathways in the brain that mediate symptoms associated with neurodevelopmental disorders such as cognitive dysfunction. Reelin signalling in multiple brain regions is involved in neuronal migration, synaptic plasticity and long-term potentiation, and has been implicated in cognitive deficits. However, how regulation of Reelin expression is affected by MIA across cortical development and associated cognitive functions remains largely unclear. Using a MIA rat model, here we demonstrate cognitive deficits in adolescent object-location memory in MIA offspring and reductions in Reln expression prenatally and in the adult prefrontal cortex. Further, developmental disturbances in gene/protein expression and DNA methylation of downstream signalling components occurred subsequent to MIA-induced Reelin dysregulation and prior to cognitive deficits. We propose that MIA-induced dysregulation of Reelin signalling contributes to the emergence of prefrontal cortex-mediated cognitive deficits through altered NMDA receptor function, resulting in inefficient long-term potentiation. Our data suggest a developmental window during which attenuation of Reelin signalling may provide a possible therapeutic target.
Maternal infection during pregnancy has been shown in epidemiological studies to increase the risk of neurodevelopmental disorders, like schizophrenia, in the developing fetus. Epigenetic mechanisms are thought to play a crucial role in linking maternal immune activation (MIA) to a higher risk of schizophrenia in offspring by disrupting normal brain development. However, our knowledge of how these epigenetic mechanisms are altered and contribute to abnormal neurodevelopment remains limited. This lack of understanding has slowed progress in identifying therapeutic targets in particular for cognitive symptoms of neurodevelopmental disorders. Focusing on the cortex of offspring exposed to MIA who showed cognitive impairments, at both prenatal and postnatal stages, here we measured tissue concentrations of S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH), using the SAM/SAH ratio as an indicator of overall methylation capacity. We also analyzed changes in the expression and activity of DNA methyltransferases (DNMTs), as well as DNA methylation (DNAm) patterns. Our findings revealed that MIA increased the SAM/SAH ratio and elevated both DNMT expression and activity in the fetal cortex. Surprisingly, these changes were not present after birth but resurfaced in adulthood, coinciding with cognitive deficits. These methylation pathway changes in adulthood were accompanied by altered DNAm patterns, with differentially methylated genes linked to schizophrenia risk and enriched in pathways related to neurodevelopment and neuronal signalling. These novel insights help establish a critical connection between MIA and epigenetic changes that contribute to cognitive deficits similar to those observed in schizophrenia.
Previous research suggests that early‐life stress (ELS) increases the risk of mental health disorders later in life. It is hypothesised that ELS disrupts the developing gut microbiome, which in turn may alter neuroendocrine and immune system development, thereby increasing disease susceptibility. However, the specific microbial taxa and pathways mediating these effects remain poorly characterised. Here, we used rat models to investigate whether ELS leads to long‐term alterations in the gut microbiome. Microbial composition was assessed using 16S rRNA Nanopore sequencing of DNA extracted from faecal pellets of adolescent male and female rats exposed to: (i) early postnatal dexamethasone (DEXA; a synthetic glucocorticoid) or saline control, (ii) prenatal stress (PRS) and controls, or (iii) postnatal stress (POS) and controls. Microbiome structure was evaluated using richness, evenness, dominance and diversity indices. We show that ELS induces model‐specific and sex‐dependent changes in gut microbiome composition, primarily at the level of overall community structure rather than individual taxa. DEXA exposure produced the most consistent compositional signature, particularly in males, whereas PRS showed minimal detectable effects and POS exhibited a more heterogeneous response characterised by increased dispersion and limited taxonomic shifts. More broadly, these findings demonstrate that integrating beta‐diversity analyses with machine learning approaches can identify reproducible microbiome patterns associated with ELS, even in the absence of large taxonomic changes. Applying similar frameworks in larger and longitudinal cohorts will be important to determine how these subtle microbial signatures contribute to long‐term physiological outcomes. image